Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)
NCT ID: NCT05416723
Last Updated: 2022-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
302 participants
OBSERVATIONAL
2022-07-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are as follows:
* Description of cases of ANCA vasculitis seen in French occupational pathology consultation centres:
* reasons for consultation,
* occupational and environmental etiologies described
* occupational situations responsible
* aptitude notices
* recognition as an occupational disease
* Identification of specific risk factors for ANCA vasculitis of occupational and/or environmental origin (exposures identified on questioning, geographical distribution of cases).
* For occupational and non-occupational cases of ANCA vasculitis: identification of difficulties encountered by patients at work and proposed work adaptations.
* Estimation of the number of applications for recognition of disabled worker status made within this patient group.
* Identification of clinical severity and autoimmune profiles of ANCA vasculitis of occupational and/or environmental origin.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892
PRO Development for ANCA Associated Vasculitis
NCT01729624
Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
NCT01731561
Prospective Longitudinal Cohort Study of Vasculitis Patients
NCT04413331
Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
NCT02126098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Seen in consultation in the occupational disease consultation centres belonging to the RNV3P
* No opposition
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux
Bordeaux, , France
CHU de Grenoble
Grenoble, , France
CHU de LILLE
Lille, , France
HCL
Lyon, , France
AP-HM
Marseille, , France
CHU de Nancy
Nancy, , France
CHU de Nantes
Nantes, , France
Hôpital Cochin ( AP-HP)
Paris, , France
CHU de Rennes
Rennes, , France
CHU de Strasbourg
Strasbourg, , France
CHU de Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANCAPRO (29BRC22.0035)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.